Published :
Tables : 62
Figures : 52
Category : Healthcare
No. of Pages : 235
Report Code : HC-U3349
Urinalysis Market is estimated to value over USD 4.57 billion by 2027 end with a CAGR of over 7.5% during the forecast period 2020 to 2027. Increased prevalence of targeted diseases, rising geriatric population are some of the key driving factors responsible for the growth of the market. Urinalysis tool is used for disease management and diagnosis. Furthermore, unmet clinical needs in the emerging nations and increasing target patient population are some other factors responsible for the urinalysis market growth. The development of advanced diagnostic tools has posed some growth opportunities for the market. Moreover, unhealthy dietary choices, sedentary lifestyle has propelled the proliferation of the market. On the other hand, a dearth of basic healthcare infrastructure in emerging countries is one of the key impediments over the market growth. Market Segmentation: By Product • Consumables • Instruments By Application • Urinary Tract Infection • Kidney Diseases • Diabetes • Liver Diseases By End User • Clinical Laboratories • Hospitals • Research and Academic • Home Healthcare By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa The global market is fragmented into product, application, end user and region. The product segment is categorised into consumables and instruments. The instruments segment is bifurcated into semi-automated and automated biochemical urine analyzers, microscopic urine analyzers and urine sediment analyzers. The instruments segment is predicted to hold the largest urinalysis market share owing to advancements in technology like urine strip readers that are fully automated and automatic urine sediment analyzers like UriSed 2 and UriSed mini. The application segment is fragmented into urinary tract infection, diabetes, hypertension, kidney diseases, and liver diseases. Urinalysis is issued for managing and treating appalling diseases like chronic kidney disease, urinary bladder cancer and diabetes. The urinary tract infection segment is anticipated to dominate the market during the forecast period owing to urinalysis providing effective diagnosis for urinary tract infection coupled with an increased number of patients diagnosed with hospital-acquired urinary tract infection. The end user segment is categorised into clinical laboratories, hospitals, research and academic and home healthcare. The clinical laboratories is anticipated to subjugate the market and this is due to increased volumes of procedures pertaining with these establishments. With automation being the current urinalysis market trend in the urine analysis diagnostics, it is anticipated to offer acceleration to the augmentation of the market. Regional Analysis: The North America region dominated the market owing to the presence of key market players, advanced healthcare infrastructure, increased disposable income and unhealthy dietary choices. The Asia pacific region, on the other hand, is anticipated to showcase substantial growth owing to a rising target population whose clinical requirements are not fulfilled, increased presence of local manufacturers. Competitive Landscape: Some of the key market players included are Seimens Healthineers, Roche Diagnostics, Cardinal Health, Arkray Inc., Sysmex Corporation, Alere Inc., Beckman Coulter, Bio-Rad Laboratories, 77 Elektronika Kft, DIRUI, ACON Laboratories, Quidel Corporation, URIT Medical Electronic Ltd. FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global urinalysis market by product, application, end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Increased prevalence of targeted diseases, rising geriatric population are some of the key driving factors responsible for the growth of the market. Urinalysis tool is used for disease management and diagnosis. Furthermore, unmet clinical needs in the emerging nations and increasing target patient population are some other factors responsible for the urinalysis market growth. The development of advanced diagnostic tools has posed some growth opportunities for the market. Moreover, unhealthy dietary choices, sedentary lifestyle has propelled the proliferation of the market. On the other hand, a dearth of basic healthcare infrastructure in emerging countries is one of the key impediments over the market growth.
Market Segmentation:
By Product • Consumables • Instruments By Application • Urinary Tract Infection • Kidney Diseases • Diabetes • Liver Diseases By End User • Clinical Laboratories • Hospitals • Research and Academic • Home Healthcare By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
The global market is fragmented into product, application, end user and region. The product segment is categorised into consumables and instruments. The instruments segment is bifurcated into semi-automated and automated biochemical urine analyzers, microscopic urine analyzers and urine sediment analyzers. The instruments segment is predicted to hold the largest urinalysis market share owing to advancements in technology like urine strip readers that are fully automated and automatic urine sediment analyzers like UriSed 2 and UriSed mini. The application segment is fragmented into urinary tract infection, diabetes, hypertension, kidney diseases, and liver diseases. Urinalysis is issued for managing and treating appalling diseases like chronic kidney disease, urinary bladder cancer and diabetes. The urinary tract infection segment is anticipated to dominate the market during the forecast period owing to urinalysis providing effective diagnosis for urinary tract infection coupled with an increased number of patients diagnosed with hospital-acquired urinary tract infection. The end user segment is categorised into clinical laboratories, hospitals, research and academic and home healthcare. The clinical laboratories is anticipated to subjugate the market and this is due to increased volumes of procedures pertaining with these establishments. With automation being the current urinalysis market trend in the urine analysis diagnostics, it is anticipated to offer acceleration to the augmentation of the market.
Regional Analysis:
The North America region dominated the market owing to the presence of key market players, advanced healthcare infrastructure, increased disposable income and unhealthy dietary choices. The Asia pacific region, on the other hand, is anticipated to showcase substantial growth owing to a rising target population whose clinical requirements are not fulfilled, increased presence of local manufacturers.
Competitive Landscape:
Some of the key market players included are Seimens Healthineers, Roche Diagnostics, Cardinal Health, Arkray Inc., Sysmex Corporation, Alere Inc., Beckman Coulter, Bio-Rad Laboratories, 77 Elektronika Kft, DIRUI, ACON Laboratories, Quidel Corporation, URIT Medical Electronic Ltd.
FutureWise Key Takeaways:
• Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global urinalysis market by product, application, end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2.Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Market Variables, Trends & Scope 4.1 Market Lineage Outlook 4.2 Penetration and Growth Prospect Mapping 4.3 Industry Value Chain Analysis 4.4 Cost Analysis Breakdown 4.5 Technology Overview 4.6 Regulatory Framework on Country Level 4.6.1 Reimbursement Framework 4.6.2 Standards and Compliances 5. Market Overview 5.1 Market Dynamics 5.1.1 Market Driver Analysis 5.1.2 Market Restraint Analysis 5.1.3 Industry Challenges 6. Market Analysis tools 6.1 Industry Analysis - Porter’s 6.1.1 Supplier Power 6.1.2 Buyer Power 6.1.3 Substitution Threat 6.1.4 Threat from new entrants 6.1.5 Competitive Rivalry 6.2 Pestel Analysis 6.2.1 Political Landscape 6.2.2 Environmental Landscape 6.2.3 Social landscape 6.2.4 Technology landscape 6.2.5 Legal Landscape 7. Urinalysis Market, By Product Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 7.1 Consumables 7.2 Instruments 7.2.1. Automated Biochemical Urine Analyzers 7.2.2. Semi-Automated Biochemical Urine Analyzers 7.2.3. Microscopic Urine Analyzers 7.2.4. Urine Sediment Analyzers 8. Urinalysis Market, By Application Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 8.1 Urinary Tract Infection 8.2 Kidney Diseases 8.3 Diabetes 8.4. Liver Diseases 9. Urinalysis Market, By End User Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 9.1 Clinical Laboratories 9.2 Hospitals 9.3 Research and Academic 9.4 Home Healthcare 10. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Mn) Analysis By Country, 2015-20110 10.2.1. U.S. 10.2.2. Canada 10.2.3. Mexico 10.2.4 Rest of North America 10.3 Market Size (USD Mn) Forecast for North America 2020-2027 11. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Regional Market Trends 11.3. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 11.3.1. Brazil 11.3.2. Venezuela 11.3.3. Argentina 11.3.4. Rest of Latin America 11.4 Market Size (US$ Mn) Forecast for Latin America 2020-2027 12. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5 Switzerland 12.2.6. Spain 12.2.7. Russia 12.2.8. Poland 12.2.9. Rest of Western Europe 12.3 Market Size (US$ Mn) Forecast for Europe 2020-2027 13. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1 Introduction 13.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019 13.2.1 Japan 13.2.2 China 13.2.3 Singapore 13.2.4 Korea 13.2.5 India 13.2.6 Australia and New Zealand 13.2.7 ASEAN 13.2.8 Rest of Asia Pacific 13.3 Market Size (US$ Mn) Forecast for Asia Pacific 2020-2027 14. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1 UAE 14.2 South Africa 14.3 Egypt 14.4 Saudi Arabia 14.5 Rest of MEA 15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 15.1 Seimens Healthineers 15.1.1. Company Overview (HQ, Business Segments, Employee Strength) 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2 Roche Diagnostics 15.2.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3 Cardinal Health 15.3.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4 Arkray Inc. 15.4.1. Company Overview (HQ, Business Segments, Employee Strength) 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5 Sysmex Corporation 15.5.1. Company Overview (HQ, Business Segments, Employee Strength) 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6 Alere Inc. 15.6.1. Company Overview (HQ, Business Segments, Employee Strength) 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7 Beckman Coulter 15.7.1. Company Overview (HQ, Business Segments, Employee Strength) 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 15.8 Bio-Rad Laboratories 15.8.1. Company Overview (HQ, Business Segments, Employee Strength) 15.8.2. Product Portfolio 15.8.3. SWOT Analysis 15.8.4. Financial Overview 15.8.5. Strategic Overview 15.9 77 Elektronika Kft 15.9.1. Company Overview (HQ, Business Segments, Employee Strength) 15.9.2. Product Portfolio 15.9.3. SWOT Analysis 15.9.4. Financial Overview 15.9.5. Strategic Overview 15.10 DIRUI 15.10.1. Company Overview (HQ, Business Segments, Employee Strength) 15.10.2. Product Portfolio 15.10.3. SWOT Analysis 15.10.4. Financial Overview 15.10.5. Strategic Overview 15.11 ACON Laboratories 15.11.1. Company Overview (HQ, Business Segments, Employee Strength) 15.11.2. Product Portfolio 15.11.3. SWOT Analysis 15.11.4. Financial Overview 15.11.5. Strategic Overview 15.12 Quidel Corporation 15.12.1. Company Overview (HQ, Business Segments, Employee Strength) 15.12.2. Product Portfolio 15.12.3. SWOT Analysis 15.12.4. Financial Overview 15.12.5. Strategic Overview 15.13 URIT Medical Electronic Ltd. 15.13.1. Company Overview (HQ, Business Segments, Employee Strength) 15.13.2. Product Portfolio 15.13.3. SWOT Analysis 15.13.4. Financial Overview 15.13.5. Strategic Overview 16. Impact of COVID-19 16.1. Positive influence on the healthcare industry 16.2. The financial disruption of the manufacturing sector 16.3. Impact of COVID-19 on emerging companies 16.4. Significant mandates in the healthcare regulations initiated by administrations 16.5. The overall economic slowdown of the developing and developed nations 17. Competitive Intelligence and Competitive Matrix 17.1 Competitive Intelligence 17.2 Competitive Matrix 18. Major Deals and Strategic Alliances Analysis 18.1 Joint ventures 18.2 Mergers and acquisitions 18.3 Licensing and partnerships 18.4 Technology Collaborations 18.5 Strategic Divestments 18.6 Market Entry Strategies 19. Relevant Case Studies and Latest News Updates 20. Research Sources and List of Primary Contacts of this Study 21. Key Market Takeaway Points from the Market Analysts at Future Market Analytics
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics